Life science and chemical instrumentation market seen reaching $90.58B by 2030

The life science and chemical instrumentation market is projected to grow from $61.82 billion in 2025 to $66.94 billion in 2026, according to The Business Research Company. The report points to rising R&D spending, lab automation and demand for advanced analytics as key drivers, with North America leading now and Asia-Pacific expected to grow fastest.

Why it matters: - Life science and chemical instrumentation underpins quality testing, manufacturing control, food safety inspections and lab data management across pharma, biotech and academic research. - The market’s growth signals continued demand for tools that support high-precision science, regulatory compliance and faster research workflows. - The category is tied to broader spending on R&D, which makes it a useful barometer for scientific and industrial investment.

What happened: - The Business Research Company released its Life Science and Chemical Instrumentation Global Market Report 2026 on Aug. 13, 2026. - The report says the market is projected to rise from $61.82 billion in 2025 to $66.94 billion in 2026. - The report forecasts the market will reach $90.58 billion by 2030. - The report estimates a 2025-2026 CAGR of 8.3% and a 2026-2030 CAGR of 7.9%. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Expanding pharmaceutical research is one driver behind the near-term market increase. - Laboratory automation is adding demand for more advanced instrumentation. - Quality control testing needs are growing across industrial and scientific settings. - Biotechnology research expansion is also supporting adoption. - Academic research funding is contributing to market growth. - Looking ahead, wider use of omics technologies, personalized medicine investment and digital laboratories are expected to support demand. - The report also points to stronger regulatory compliance automation and higher demand for real-time analytical data. - Key trends include automated analytical instruments, high-throughput testing, better integration of laboratory information management systems, precision measurement technologies and tighter focus on data integrity. - The market covers instruments used in industrial labs, pharmaceutical companies, biotechnology firms and academic institutions. - The report says the tools help monitor and regulate research and development activities. - Eurostat reported in September 2025 that EU R&D spending reached 2.26% of GDP in 2023, up from 2.22% in 2022.

Between the lines: - The forecast suggests buyers are shifting toward connected, automated systems that can handle more data and tighter compliance demands. - The strongest growth themes are not just higher testing volume, but also more digital lab workflows and better measurement accuracy. - Regional leadership remains with North America, but the faster Asia-Pacific outlook suggests the market’s next wave of expansion may come from broader global research investment.

What's next: - The report expects more adoption of automated analytical instruments and laboratory information management systems. - Companies will likely keep investing in tools that improve speed, data integrity and regulatory readiness. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics and tables. - The company offers a free sample report and the full market report. - The release also lists contact information for Saumya Sahay and The Business Research Company.

The bottom line: - The market is growing steadily now and is set to expand further as labs automate, research spending rises and demand increases for faster, more reliable scientific instrumentation.